Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defective efferocytosis of vascular cells in heart disease. | Front Cardiovasc Med | 2022 | 36247464 | PubTator, text mining | PubMed |
| High expression of glycolysis-related PGM2 gene in relation to poor prognosis and deficient immune cells infiltration in lung adenocarcinoma: a study based on bioinformatics analysis. | J Thorac Dis | 2022 | 36245582 | PubTator, text mining | PubMed |
| Impacts of microplastics on immunity. | Front Toxicol | 2022 | 36238600 | PubTator, text mining | PubMed |
| Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis. | Transl Cancer Res | 2022 | 36237258 | PubTator, text mining | PubMed |
| Protein Acetylation Going Viral: Implications in Antiviral Immunity and Viral Infection. | Int J Mol Sci | 2022 | 36232610 | PubTator, text mining | PubMed |
| Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol. | Cells | 2022 | 36231033 | PubTator, text mining | PubMed |
| Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma. | Cancers (Basel) | 2022 | 36230507 | PubTator, text mining | PubMed |
| Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma. | Aging (Albany NY) | 2022 | 36227151 | PubTator, text mining | PubMed |
| Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. | Front Immunol | 2022 | 36225934 | PubTator, text mining | PubMed |
| Dynamics of transcriptome and chromatin accessibility revealed sequential regulation of potential transcription factors during the brown adipose tissue whitening in rabbits. | Front Cell Dev Biol | 2022 | 36225319 | PubTator, text mining | PubMed |
| On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs. | J Diabetes Complications | 2022 | 36215794 | PubTator, text mining | PubMed |
| Aquaporins: New players in breast cancer progression and treatment response. | Front Oncol | 2022 | 36212456 | PubTator, text mining | PubMed |
| Non-coding ribonucleic acid-mediated CAMSAP1 upregulation leads to poor prognosis with suppressed immune infiltration in liver hepatocellular carcinoma. | Front Genet | 2022 | 36212130 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma. | Front Cell Infect Microbiol | 2022 | 36204642 | PubTator, text mining | PubMed |
| Functional inference of gene regulation using single-cell multi-omics. | Cell Genom | 2022 | 36204155 | PubTator, text mining | PubMed |
| LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration. | Front Genet | 2022 | 36199576 | PubTator, text mining | PubMed |
| Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection. | Virol J | 2022 | 36192760 | PubTator, text mining | PubMed |
| The role of macrophage subtypes and exosomes in immunomodulation. | Cell Mol Biol Lett | 2022 | 36192691 | PubTator, text mining | PubMed |
| IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. | Front Immunol | 2022 | 36189314 | PubTator, text mining | PubMed |
| Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. | Front Immunol | 2022 | 36189286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=40